NCT00769106 2016-04-14
HCC-CIK
Sun Yat-sen University
Phase 3 Completed
Clinical Trials
3 trialsNCT00849264 2016-04-01
Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients
Eastern Hepatobiliary Surgery Hospital
Phase 2 Completed
NCT00827177 2014-01-24
Dose Escalation Study of ARQ 197 in Combination With Sorafenib in Adult Patients With Advanced Solid Tumors
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Phase 1 Completed